Cas no 537039-17-1 (5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine)
5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine Chemical and Physical Properties
Names and Identifiers
-
- 5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine
- 1H-Pyrazol-3-amine,5-(4-methyl-1-piperazinyl)-(9CI)
- 3-(4-methylpiperazin-1-yl)-1H-pyrazol-5-amine
- MFCD17392875
- AKOS022184304
- DB-107122
- 5-(4-methylpiperazin-1-yl)-1H-pyrazol-3-amine dihydrochloroide
- CS-0188353
- 1H-Pyrazol-3-amine,5-(4-methyl-1-piperazinyl)-
- AT18284
- BS-17542
- SY290469
- 3-Amino-5-(4-methyl-1-piperazinyl)pyrazole
- SCHEMBL922677
- 537039-17-1
- DTXSID30668132
- BAUIMKSJWJHSBP-UHFFFAOYSA-N
- 5-(4-Methyl-piperazin-1-yl)-2H-pyrazol-3-ylamine
-
- Inchi: 1S/C8H15N5/c1-12-2-4-13(5-3-12)8-6-7(9)10-11-8/h6H,2-5H2,1H3,(H3,9,10,11)
- InChI Key: BAUIMKSJWJHSBP-UHFFFAOYSA-N
- SMILES: N1(C2C=C(N)NN=2)CCN(C)CC1
Computed Properties
- Exact Mass: 181.13274550g/mol
- Monoisotopic Mass: 181.13274550g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 13
- Rotatable Bond Count: 1
- Complexity: 166
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.1
- Topological Polar Surface Area: 61.2?2
Experimental Properties
- Density: 1.236
5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-BS276-100mg |
5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine |
537039-17-1 | 95+% | 100mg |
844CNY | 2021-05-07 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-BS276-250mg |
5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine |
537039-17-1 | 95+% | 250mg |
2027CNY | 2021-05-07 | |
| Chemenu | CM170019-1g |
5-(4-methylpiperazin-1-yl)-1H-pyrazol-3-amine |
537039-17-1 | 95% | 1g |
$439 | 2021-08-05 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-BS276-50mg |
5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine |
537039-17-1 | 95+% | 50mg |
507.0CNY | 2021-07-17 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-BS276-200mg |
5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine |
537039-17-1 | 95+% | 200mg |
1269.0CNY | 2021-07-17 | |
| Chemenu | CM170019-250mg |
5-(4-methylpiperazin-1-yl)-1H-pyrazol-3-amine |
537039-17-1 | 95%+ | 250mg |
$*** | 2023-05-30 | |
| Chemenu | CM170019-1g |
5-(4-methylpiperazin-1-yl)-1H-pyrazol-3-amine |
537039-17-1 | 95%+ | 1g |
$*** | 2023-05-30 | |
| eNovation Chemicals LLC | Y1265144-100mg |
1H-Pyrazol-3-amine,5-(4-methyl-1-piperazinyl)-(9CI) |
537039-17-1 | 95% | 100mg |
$230 | 2024-06-06 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X56975-100mg |
5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine |
537039-17-1 | 95% | 100mg |
¥790.0 | 2024-07-16 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | X56975-250mg |
5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine |
537039-17-1 | 95% | 250mg |
¥1382.0 | 2024-07-16 |
5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine Related Literature
-
Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
-
Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
-
Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
-
Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
-
Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592
Additional information on 5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine
Comprehensive Overview of 5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine (CAS No. 537039-17-1)
5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine, with the CAS number 537039-17-1, is a specialized organic compound that has garnered significant attention in pharmaceutical and biochemical research. This compound belongs to the class of heterocyclic amines, featuring a pyrazole core substituted with a 4-methylpiperazine moiety. Its unique structural attributes make it a valuable intermediate in the synthesis of bioactive molecules, particularly in the development of kinase inhibitors and receptor modulators.
The growing interest in 5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine is driven by its potential applications in drug discovery. Researchers are actively exploring its role in targeting protein-protein interactions and signal transduction pathways, which are critical in diseases such as cancer and inflammatory disorders. The compound's amine functionality and piperazine ring contribute to its ability to form stable interactions with biological targets, enhancing its utility in medicinal chemistry.
In recent years, the demand for high-purity heterocyclic compounds like 5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine has surged, particularly in the context of precision medicine and personalized therapeutics. This trend aligns with the broader shift toward targeted drug delivery systems and small-molecule therapeutics. The compound's CAS No. 537039-17-1 is frequently searched in academic and industrial databases, reflecting its relevance in contemporary research.
From a synthetic perspective, 5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine is often prepared via nucleophilic substitution reactions or catalytic coupling methodologies. Its pyrazole-amine scaffold is amenable to further derivatization, enabling the creation of diverse analogs with tailored properties. This flexibility has made it a focal point in structure-activity relationship (SAR) studies, where researchers aim to optimize pharmacokinetic profiles and binding affinities.
The compound's physicochemical properties, such as solubility and stability, are also of interest to formulators and process chemists. Its logP value and hydrogen-bonding capacity influence its behavior in biological systems, making it a subject of ADME (Absorption, Distribution, Metabolism, and Excretion) studies. These factors are critical for ensuring bioavailability and therapeutic efficacy in preclinical and clinical settings.
In the context of green chemistry, efforts are underway to develop more sustainable synthetic routes for 5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine. Researchers are exploring catalyst-free reactions and solvent-free conditions to minimize environmental impact. This aligns with the broader industry focus on eco-friendly synthesis and reduced waste generation.
As the scientific community continues to investigate 5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine, its potential extends beyond traditional drug development. Emerging applications include its use in chemical biology probes and diagnostic tools, where its selective binding properties can be leveraged for imaging and detection purposes. The compound's versatility underscores its importance in both basic research and applied sciences.
In summary, 5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine (CAS No. 537039-17-1) represents a promising scaffold with multifaceted applications in modern science. Its integration into drug discovery pipelines and biochemical assays highlights its enduring value. As research progresses, this compound is poised to play a pivotal role in advancing therapeutic innovations and scientific understanding.
537039-17-1 (5-(4-Methylpiperazin-1-yl)-1H-pyrazol-3-amine) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)